Matthew Hanchard, PhD is a Research Fellow working in academia, with two books, fifteen articles, eight years of teaching acumen in higher education, and extensive industry experience. He works around pharma, data, and open science. At present his work focusses on health economics arguments over orphan drug pricing strategy, with market access as a key area of interest. Matthew also had a firm interested in real-world data/evidence (RWD/RWE). He is based in the UK, and open to networking.